Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Innoviva Inc
(NQ:
INVA
)
18.87
-0.18 (-0.94%)
Streaming Delayed Price
Updated: 11:09 AM EST, Nov 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Innoviva Inc
< Previous
1
2
3
4
Next >
Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
July 27, 2022
From
Innoviva, Inc.
Via
Business Wire
Overview Of Value Stocks In The Healthcare Sector
July 25, 2022
What is a Value Stock?
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022
July 20, 2022
Upgrades
Via
Benzinga
Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share
May 23, 2022
Via
Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
July 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 13, 2022
Gainers
Via
Benzinga
Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests
July 13, 2022
Via
Benzinga
Innoviva Sells 15% Economic Stake in Theravance Respiratory Company to Royalty Pharma for approximately $282 million plus full ownership of existing equity investments and the potential for $50 million milestone payment
July 13, 2022
From
Innoviva, Inc.
Via
Business Wire
La Jolla Pharmaceutical (LJPC) Stock Skyrockets on Innoviva Acquisition News
July 11, 2022
A headline-grabbing takeover deal could be impactful for the medical community - and today, it's definitely huge news for LJPC stock holders.
Via
InvestorPlace
Innoviva Completes Acquisition of Entasis Therapeutics
July 11, 2022
From
Innoviva, Inc.
Via
Business Wire
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death
July 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal
July 11, 2022
Via
Benzinga
Innoviva to Acquire La Jolla Pharmaceutical Company
July 11, 2022
From
La Jolla Pharmaceutical Company
Via
Business Wire
Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.
July 08, 2022
From
Innoviva, Inc.
Via
Business Wire
5 Value Stocks To Watch In The Healthcare Sector
June 27, 2022
What Defines a Value Stock?
Via
Benzinga
Innoviva to Acquire Entasis Therapeutics
May 23, 2022
From
Innoviva, Inc.
Via
Business Wire
Innoviva Reports First Quarter 2022 Financial Results
April 27, 2022
From
Innoviva, Inc.
Via
Business Wire
Overview Of Value Stocks In The Healthcare Sector
March 28, 2022
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Sail Through the Choppy Market With These 4 Low-Beta Stocks
March 05, 2022
Creating a portfolio of low-beta stocks is important since the securities can deliver healthy returns and provide a shield against volatile market conditions.
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 11, 2022
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock rose 29.0% to $1.38 during Friday's pre-market session. The company's market cap stands at $11.4 million. Innoviva...
Via
Benzinga
62 Biggest Movers From Yesterday
February 11, 2022
Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 42.8% to close at $3.07 on Thursday following the company's recent uplisting to the Nasdaq....
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Armata Pharma's Largest Shareholder Injects $45M For Its Bacteriophage Development
February 10, 2022
Armata Pharmaceuticals Inc (NYSE: ARMP) has
Via
Benzinga
Innoviva Reports Fourth Quarter 2021 Financial Results
February 09, 2022
From
Innoviva, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
February 02, 2022
Good morning, investor! We're beginning another busy day of trading with a look at the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
10 Stocks to Buy That Could Make You a Millionaire in 2022
January 26, 2022
After this past year, it's going to be hard to find stocks to buy to make you a millionaire in 2022. Here are 10 that might do the trick.
Via
InvestorPlace
7 of the Top-Rated Pharmaceutical Stocks for Q1
January 18, 2022
As the market begins to shift from high-growth, tech-fueled start-ups, one good long-term growth option is quality pharmaceutical stocks.
Via
InvestorPlace
5 Value Stocks In The Healthcare Sector
December 20, 2021
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
December 06, 2021
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples...
Via
Benzinga
Innoviva Reports Third Quarter 2021 Financial Results
October 27, 2021
From
Innoviva, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.